REFERENCES

1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol.2012; 8:228-36.
2. International Diabetes Federation. IDF Diabetes Atlas, 8^th edn. Brussels, Belgium, 2017.
3. Screening for Type 2 Diabetes, American diabetes association. Diabetes care2004; 27 (1): S11-S14.
4. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412–423.
5. Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS) Diabetes Care. 2010; 33:1497–1499.
6. Alessandra Geraci, Renzo Bianchi, Antonio Sanfilippo, Michele D’ Arienzo. Dupuytren contracture in diabetic hand: Endocrinology Studies. 2011;1:e2
7. Eczema Cl, Iwelu EV, Abaraogu UO, Olawale OA. Handgrip strength in individuals with long-standing type 2 diabetes mellitus: A premilimnary report. African J physiother Rehab Sci 2012; 4 (1-2): 67-71.
8. Seok Won Park, Bret H Goodpaster, Elsa S. Strotmeyer. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: Diabetes care.2007;30 (6)1507-1512
9. Sayer,AA., E.M Denninson, H.E. syddal, H.JGilbody, D.I. Philipsand C. Cooper:Type2 diabetes muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care2005;28:2541-2
10. S.ABus, Q.X.Yang,J.H. Wang, M.B.Smith,R.Wunderlich,P.R.Cavangh, Intrensic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study,Diabetes Care25 (2002)1444-1450
11. Pedersen M, Brunnsgaard H, Weis N et al. Circulating levels of TNF-alpha and IL-6 relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech AgeingDev2003; 124: 495-502.
12. Helmersson, J., B. Vessby, A. Larsson and S. Basu 2004. Association of type 2 diabetes with cyclooxygenase mediated inflammation and oxidative stress in an elderly population. Circulation109: 1729-1734
13. Tae Nyun Kim, Man Sik Park, Sae Jeong Yang et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes. The Korean sarcopenic obesity study, Diabetes care. 2010;33(7):1497-1499
14. T. Herman IJzeman, Nicholas C. Schaper, Tom Melai Kennethmeijer. Lower extremity muscle strength is reduced in people with type 2 diabetes, with or without polyneuropathy. And is associated with impaired mobility and reduced quality of life. Diabetes research and clinical practice.2012;3:345-351
15. AndressenCS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy.Diabetes. 2006;55(3):806-12
16. Miho Nishitani, Kauzunori Shimada, Satoshi Sunayama. Impact of diabetes on muscle mass, muscle strength, and exercise tolerance in patients after coronary artery bypass grafting. Journal of cardiology. 2011;58(2):173-180
17. Akanhsha, Vivek Dixit, Dr. Dinesh Dhanwal. Handgrip strength as a measure of sarcopenia in type 2 diabetes Mellitus. J. Adv. Res. Med. 2014;1(1): 10-14